Skip to Main Content

Author Details

David J H Shih
University of Texas MD Anderson Cancer Center Houston
2009
46
32
PMIDPaper TitleJournal TitlePublished Year
35141022Exploiting induced vulnerability to overcome PARPi resistance and clonal heterogeneity in BRCA mutant triple-negative inflammatory breast cancer.Am J Cancer Res2022
35176131CNGPLD: case-control copy-number analysis using Gaussian process latent difference.Bioinformatics2022
34066883A Gene Expression Signature to Predict Nucleotide Excision Repair Defects and Novel Therapeutic Approaches.Int J Mol Sci2021
32286280Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.Nat Commun2020
32612833Role of DNA repair defects in predicting immunotherapy response.Biomark Res2020
32109374Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.Cancer Cell2020
32286303Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas.Nat Commun2020
32577620The Tale of CHD4 in DNA Damage Response and Chemotherapeutic Response.J Cancer Res Cell Ther2019
29474906A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.Cell2018
30019219Heterogeneity within the PF-EPN-B ependymoma subgroup.Acta Neuropathol2018
29856958A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.Cell2018
28609654Intertumoral Heterogeneity within Medulloblastoma Subgroups.Cancer Cell2017
28394352Spatial heterogeneity in medulloblastoma.Nat Genet2017
28504719Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.Oncogene2017
26760213Divergent clonal selection dominates medulloblastoma at recurrence.Nature2016
26976201Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.Lancet Oncol2016
25336695Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups.Clin Cancer Res2015
25957288Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype.Clin Cancer Res2015
25739120Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.Oncotarget2015
24493713Cytogenetic prognostication within medulloblastoma subgroups.J Clin Oncol2014
25539912WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma.Acta Neuropathol Commun2014
25584369Response.J Neurosurg2014
25245477Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.J Neurosurg2014
25043047Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.Nature2014
25150496The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma.Nat Med2014
25136069Epigenetic states of cells of origin and tumor evolution drive tumor-initiating cell phenotype and tumor heterogeneity.Cancer Res2014
24831600MRI surrogates for molecular subgroups of medulloblastoma.AJNR Am J Neuroradiol2014
24616042Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent.Pediatr Blood Cancer2014
24553142Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.Nature2014
24651015Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.Cancer Cell2014
23184418Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.Acta Neuropathol2013
24067506Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases.Cancer Res2013
24092238MyoD is a tumor suppressor gene in medulloblastoma.Cancer Res2013
24140199Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.Lancet Oncol2013
24174164TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.Acta Neuropathol2013
23852537Notch1-induced brain tumor models the sonic hedgehog subgroup of human medulloblastoma.Cancer Res2013
23835706Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.J Clin Oncol2013
22057785Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.Acta Neuropathol2012
23019410High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis.Neoplasia2012
22832583Dissecting the genomic complexity underlying medulloblastoma.Nature2012
22832581Subgroup-specific structural variation across 1,000 medulloblastoma genomes.Nature2012
22265402Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.Cell2012
22358458Subgroup-specific alternative splicing in medulloblastoma.Acta Neuropathol2012
22343890Clonal selection drives genetic divergence of metastatic medulloblastoma.Nature2012
21681522Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct.Acta Neuropathol2011
19962671Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors.Cancer Cell2009
  • 1 - 46 of 46

Recommended Authors

St. Jude Children's Research Hospital
Career Start Year 2018
Number of shared co-authors 66
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2018
Number of shared co-authors 27
German Cancer Research Center (DKFZ)
Career Start Year 2018
Number of shared co-authors 20
German Cancer Research Center (DKFZ)
Career Start Year 2017
Number of shared co-authors 17
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2016
Number of shared co-authors 67
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2014
Number of shared co-authors 70
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 11
National Cancer Institute
Career Start Year 2013
Number of shared co-authors 10
Institute of Pathology, Charite Universitatsmedizin Berlin
Career Start Year 2013
Number of shared co-authors 14
University of California San Diego
Career Start Year 2013
Number of shared co-authors 30
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 8
Graduate School of Medicine, Kyoto University
Career Start Year 2012
Number of shared co-authors 77
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2012
Number of shared co-authors 71
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 5
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 77
University of Michigan-Ann Arbor
Career Start Year 2010
Number of shared co-authors 32
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 6
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 3
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 26
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 39
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 31
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 25
St Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 37
University of California san francisco
Career Start Year 2003
Number of shared co-authors 55
St. Jude Children's Research Hospital
Career Start Year 2002
Number of shared co-authors 58
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 69
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 17
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 41
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 63
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 26

Collaborators

The Hospital for Sick Children
Co-authored papers 37
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 26
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 24
St Jude Children's Research Hospital
Co-authored papers 24
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 21
The Hospital for Sick Children
Co-authored papers 21
The Hospital for Sick Children
Co-authored papers 20
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 20
Hospital for Sick Children
Co-authored papers 20
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 19
Hospital for Sick Children
Co-authored papers 18
Co-authored papers 17
University of California san francisco
Co-authored papers 16
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 15
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 14
Harvard Medical School
Co-authored papers 12
Dana-Farber Cancer Institute
Co-authored papers 12
St Jude Children's Research Hospital
Co-authored papers 12
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers 12
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 11
Co-authored papers 11
The Chinese University of Hong Kong, Prince of Wales Hospital
Co-authored papers 11
The Hospital for Sick Children
Co-authored papers 11
Hospital for Sick Children
Co-authored papers 11
Children's Memorial Health Institute
Co-authored papers 11
University of Wollongong
Co-authored papers 11
The Hospital for Sick Children, University of Toronto
Co-authored papers 11
University Medical Center Hamburg-Eppendorf
Co-authored papers 10
Cumming School of Medicine, University of Calgary
Co-authored papers 10
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 10